Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Examine the tax effects of rebalancing a portfolio and practical ways to minimize tax impact. This intro covers common scenarios and planning ideas.
21,738 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Today's market action centers on semiconductor chatter, a solid Micron after-hours surge, and a mixed read across maj...
Snap is playing a high-stakes game. This article breaks down snap’s specs gamble, what it would take for AR hardware ...
SPHY has delivered monthly income since 2012, but 2026 tests whether its high-yield payout can withstand cyclical str...
Lam Research sits at the core of AI infrastructure tooling. This article explores whether the company could research ...
A surge in AI workloads hinges on memory, and Micron’s latest signals hint at lasting strength. This piece unpacks wh...
Three blue-chip names have slipped on the chart while trading below intrinsic value, offering income and upside for p...
SpaceX wiped out most of its early IPO surge as trading shifted toward a new Nasdaq-100 opening. The stock is testing...
When a tech titan reshuffles its gaming division, investors pay attention. This article breaks down the potential sto...
Chipotle stock has surged about 17% in the last month as investors anticipate July earnings. This article breaks down...
Oklo faced a sharp pullback in early 2026 as sector bets cooled and financing moves pressured shares. This guide brea...
Investors weighing Dow and LYB face a crossroads in 2026. This guide breaks down business models, catalysts, risks, a...